BRAIDWELL LP
Q3 2026 Form 13-F
STAMFORD, CONNECTICUT
CIK 0001920938
· CRD 316988
· SEC-registered investment adviser
$2.4B Reported Value Total
BRAIDWELL LP reports 13 total accounts under management (AUM). There are 13 discretionary accounts valued at $3,632,464,658, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
13 funds
· $3.6B gross asset value
Hedge Fund: $3.6B · Private Equity Fund: $0
Source: Form ADV filed 2026-09-22
Reported value
$2.4B
Quarter over quarter
+7.3%
Holdings
86
Top-10 concentration
30.7%
Key People
Form ADV owners & control persons
Alexander Thomas Karnal
LIMITED PARTNER
Brian James Kreiter
LIMITED PARTNER
Ken C Joseph
CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 16, 2026 |
| Form | 13F-HR |
| Reported value | $2.4B |
| Positions | 86 |
| Change in reported value | -10.9% |
| New positions | 16 |
| Exited positions | 14 |
| Position turnover | 30.0% |
| Top-10 concentration | 30.7% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
86 | $2.4B |
|
Q2 2026 13F
Filed Aug 14, 2026
|
83 | $2.7B |
|
Q1 2026 13F
Filed May 15, 2026
|
82 | $3.0B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
68 | $3.1B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
64 | $3.4B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
45 | $2.9B |
|
Q1 2025 13F
Filed May 15, 2025
|
52 | $2.8B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
59 | $3.4B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
65 | $3.5B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
58 | $3.2B |
|
Q1 2024 13F
Filed May 15, 2024
|
51 | $3.1B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
47 | $2.7B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
60 | $3.2B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
58 | $3.1B |
|
Q1 2023 13F
Filed May 15, 2023
|
57 | $3.0B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
63 | $3.0B |
Top 20 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | KOD KODIAK SCIENCES INC | $102.9M | 4.27% |
| 2 | CAI CARIS LIFE SCIENCES INC | $84.1M | 3.49% |
| 3 | EWTX EDGEWISE THERAPEUTICS INC | $84.0M | 3.49% |
| 4 | ATEC ALPHATEC HLDGS INC | $74.6M | 3.1% |
| 5 | IRTC IRHYTHM HOLDINGS INC | $72.8M | 3.02% |
| 6 | ATEC 0.75 03/15/30 ALPHATEC HLDGS INC | $69.3M | 2.88% |
| 7 | HNGE HINGE HEALTH INC | $63.7M | 2.64% |
| 8 | SYRE SPYRE THERAPEUTICS INC | $63.6M | 2.64% |
| 9 | XENE XENON PHARMACEUTICALS INC | $63.5M | 2.64% |
| 10 | NEO NEOGENOMICS INC | $61.5M | 2.55% |
| 11 | GKOS GLAUKOS CORP | $56.5M | 2.34% |
| 12 | VERA VERA THERAPEUTICS INC | $55.8M | 2.31% |
| 13 | TMDX TRANSMEDICS GROUP INC | $54.6M | 2.27% |
| 14 | ISRG INTUITIVE SURGICAL INC | $51.2M | 2.13% |
| 15 | AVAH AVEANNA HEALTHCARE HLDGS INC | $48.0M | 1.99% |
| 16 | NBIX NEUROCRINE BIOSCIENCES INC | $47.7M | 1.98% |
| 17 | DNTH DIANTHUS THERAPEUTICS INC | $45.6M | 1.89% |
| 18 | BTSG BRIGHTSPRING HEALTH SVCS INC | $45.5M | 1.89% |
| 19 | GENB GENERATE BIOMEDICINES INC | $44.5M | 1.85% |
| 20 | MRVI MARAVAI LIFESCIENCES HLDGS I | $42.2M | 1.75% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.